Selected research
Industry Research
Agomelatine API Industry Research Report 2026
Market perspective
The global Agomelatine API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Agomelatine API is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Agomelatine API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Agomelatine API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Agomelatine API include among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Agomelatine API market in revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Agomelatine API.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Agomelatine API Market by Company
Msn Pharmachem Private Ltd
Jiangsu Hansoh Pharmaceutical Group
Yangtze River Pharmaceutical
Agomelatine API Segment by Type
Purity ≥99%
98%≤purity≤99%
Agomelatine API Segment by Application
Tablets
Others
Agomelatine API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Agomelatine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Agomelatine API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Agomelatine API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Agomelatine API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Agomelatine API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Agomelatine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity ≥99%
- 98%≤purity≤99%
Applications
- Tablets
- Others
Companies covered
- Msn Pharmachem Private Ltd
- Jiangsu Hansoh Pharmaceutical Group
- Yangtze River Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Agomelatine API by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Purity ≥99%
- 2.2.3 98%≤purity≤99%
- 2.3 Agomelatine API by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablets
- 2.3.3 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Agomelatine API Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Agomelatine API Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Agomelatine API Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Agomelatine API Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Agomelatine API Production by Manufacturers (2021-2026)
- 3.2 Global Agomelatine API Production Value by Manufacturers (2021-2026)
- 3.3 Global Agomelatine API Average Price by Manufacturers (2021-2026)
- 3.4 Global Agomelatine API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Agomelatine API Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Agomelatine API Manufacturers, Product Type & Application
- 3.7 Global Agomelatine API Manufacturers Established Date
- 3.8 Global Agomelatine API Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Msn Pharmachem Private Ltd
- 4.1.1 Msn Pharmachem Private Ltd Agomelatine API Company Information
- 4.1.2 Msn Pharmachem Private Ltd Agomelatine API Business Overview
- 4.1.3 Msn Pharmachem Private Ltd Agomelatine API Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Msn Pharmachem Private Ltd Product Portfolio
- 4.1.5 Msn Pharmachem Private Ltd Recent Developments
- 4.2 Jiangsu Hansoh Pharmaceutical Group
- 4.2.1 Jiangsu Hansoh Pharmaceutical Group Agomelatine API Company Information
- 4.2.2 Jiangsu Hansoh Pharmaceutical Group Agomelatine API Business Overview
- 4.2.3 Jiangsu Hansoh Pharmaceutical Group Agomelatine API Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Jiangsu Hansoh Pharmaceutical Group Product Portfolio
- 4.2.5 Jiangsu Hansoh Pharmaceutical Group Recent Developments
- 4.3 Yangtze River Pharmaceutical
- 4.3.1 Yangtze River Pharmaceutical Agomelatine API Company Information
- 4.3.2 Yangtze River Pharmaceutical Agomelatine API Business Overview
- 4.3.3 Yangtze River Pharmaceutical Agomelatine API Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Yangtze River Pharmaceutical Product Portfolio
- 4.3.5 Yangtze River Pharmaceutical Recent Developments
5 Global Agomelatine API Production by Region
- 5.1 Global Agomelatine API Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Agomelatine API Production by Region: 2021-2032
- 5.2.1 Global Agomelatine API Production by Region: 2021-2026
- 5.2.2 Global Agomelatine API Production Forecast by Region (2027-2032)
- 5.3 Global Agomelatine API Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Agomelatine API Production Value by Region: 2021-2032
- 5.4.1 Global Agomelatine API Production Value by Region: 2021-2026
- 5.4.2 Global Agomelatine API Production Value Forecast by Region (2027-2032)
- 5.5 Global Agomelatine API Market Price Analysis by Region (2021-2026)
- 5.6 Global Agomelatine API Production and Value, YOY Growth
- 5.6.1 North America Agomelatine API Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Agomelatine API Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Agomelatine API Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Agomelatine API Production Value Estimates and Forecasts (2021-2032)
6 Global Agomelatine API Consumption by Region
- 6.1 Global Agomelatine API Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Agomelatine API Consumption by Region (2021-2032)
- 6.2.1 Global Agomelatine API Consumption by Region: 2021-2026
- 6.2.2 Global Agomelatine API Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Agomelatine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Agomelatine API Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Agomelatine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Agomelatine API Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Agomelatine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Agomelatine API Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Agomelatine API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Agomelatine API Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Agomelatine API Production by Type (2021-2032)
- 7.1.1 Global Agomelatine API Production by Type (2021-2032) & (Tons)
- 7.1.2 Global Agomelatine API Production Market Share by Type (2021-2032)
- 7.2 Global Agomelatine API Production Value by Type (2021-2032)
- 7.2.1 Global Agomelatine API Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Agomelatine API Production Value Market Share by Type (2021-2032)
- 7.3 Global Agomelatine API Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Agomelatine API Production by Application (2021-2032)
- 8.1.1 Global Agomelatine API Production by Application (2021-2032) & (Tons)
- 8.1.2 Global Agomelatine API Production Market Share by Application (2021-2032)
- 8.2 Global Agomelatine API Production Value by Application (2021-2032)
- 8.2.1 Global Agomelatine API Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Agomelatine API Production Value Market Share by Application (2021-2032)
- 8.3 Global Agomelatine API Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Agomelatine API Value Chain Analysis
- 9.1.1 Agomelatine API Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Agomelatine API Production Mode & Process
- 9.2 Agomelatine API Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Agomelatine API Distributors
- 9.2.3 Agomelatine API Customers
10 Global Agomelatine API Analyzing Market Dynamics
- 10.1 Agomelatine API Industry Trends
- 10.2 Agomelatine API Industry Drivers
- 10.3 Agomelatine API Industry Opportunities and Challenges
- 10.4 Agomelatine API Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst